Mobilization of Emotions and Empathy During Communication Training in Nursing Students (AEI-Sim)

October 1, 2026 updated by: University of Padova

Assessment of Emotional and Empathic Involvement During Simulation-Based Communication Training in Nursing Students

Effective communication in healthcare is vital for patient satisfaction, safety, outcomes, and ethical practice, supporting shared decision-making and informed consent. Simulation-based training is widely used to strengthen communication skills and foster empathy through emotionally engaging experiences.

This is a pilot study aimed (1) to assess changes in emotional state and empathy in nursing students after a simulation-based workshop (SBW) on delivering bad news, and (2) to evaluate the sensitivity of standardized scales in detecting these changes.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

This observational, longitudinal, descriptive study will be conducted among advanced nursing students participating in a six-hour Simulation-Based Workshop (SBW) comprising three sessions. In Session 1, students will discuss the SPIKES protocol for communicating bad news and analyze a clinical case. Baseline affective states will be assessed using the Positive and Negative Affect Schedule (PANAS). In Session 2, students will participate in role-plays with simulated patients (SPs). Immediately following the role-plays, students will record their emotional reflections (ER) and complete the Jefferson Scale of Empathy for Health Professionals (JSE-HP), the Jefferson Scale of Patient Perceptions of Physician Empathy (JSPPPE), adapted to assess healthcare professional communication, and the PANAS. Instructors and SPs will also complete the adapted JSPPPE to evaluate students' empathic communication. In Session 3, students will participate in a structured debriefing, after which ER, JSE-HP, and JSPPPE will be reassessed.

The PANAS will be used to assess affective states through 20 items comprising 10 positive-affect (PA) and 10 negative-affect (NA) items. Higher PA scores will indicate greater levels of enthusiasm and motivation, whereas lower scores will reflect reduced energy and sadness. Higher NA scores will indicate greater negative affect, including feelings of anger and disgust, while lower scores will reflect calmer and more serene emotional states.

The JSE-HP will be used to assess empathy in healthcare professionals, particularly their ability to understand and communicate patients' perspectives. The instrument comprises 20 items rated on a 7-point Likert scale, yielding total scores ranging from 20 to 140, with higher scores indicating a greater empathic orientation.

The JSPPPE will be used to assess perceptions of healthcare professionals' empathic communication. The five-item instrument will be rated on a 7-point Likert scale and will assess dimensions including understanding, concern, and perspective-taking. Total scores will range from 5 to 35, with higher scores indicating greater perceived empathy.

Study Type

Observational

Enrollment (Estimated)

10

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Advanced students from nursing or other healthcare professions who conduct a simulation-based workshop as part of their communication training curriculum.

Description

Inclusion Criteria:

  • Advanced students of healthcare professions.

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: OTHER
  • Time Perspectives: OTHER

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of emotions after the simulation-based workshop on communication of bad news
Time Frame: PANAS scores will be assessed at three time points: after Session 1 (baseline; Day 0), Session 2 (simulation; Day 7), and Session 3 (debriefing; Day 14), scheduled for April 1 (Day 0), 8 (session 2), and 15 (session 3), 2027, respectively.

Questionnaires from the PANAS will be completed by the participants.

PANAS scores will be assessed at three time points: after Session 1 (baseline; Day 0), Session 2 (simulation; Day 7), and Session 3 (debriefing; Day 14), scheduled for April 1 (Day 0), 8 (session 2), and 15 (session 3), 2027, respectively.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes of empathy during a simulation-based workshop on communication of bad news measured by Jefferson Scale of Empathy.
Time Frame: Students will complete the JSE-HP questionnaire after sessions two (S2) and three (S3) of the three-stage, simulation-based workshop on communicating bad news. S2 is planed to take place on April 8, 2027, and S3 on April 15, 2027.

Participants will assess changes in their conceptualizations of empathy by completing the Health Professions Version of the Jefferson Scale of Empathy (JSE-HP).

Students will complete the JSE-HP questionnaire after sessions two (S2) and three (S3) of the three-stage, simulation-based workshop on communicating bad news. S2 is planed to take place on April 8, 2027, and S3 on April 15, 2027.
Changes of perceived empathy after participating in a simulation-based workshop on communication of bad news measured by Jefferson Scale of Patient Perceptions of Physician Empathy
Time Frame: Complete the JSPPPE after sessions two and three, or the simulation and debriefing days (April 8 and 15, 2027 respectively), of the three-stage, simulation-based workshop on communicating bad news.

Self-perceived empathy will be scored during the communication of bad news using the Jefferson Scale of Patient Perceptions of Physician Empathy (JSPPPE).

Complete the JSPPPE after sessions two and three, or the simulation and debriefing days (April 8 and 15, 2027 respectively), of the three-stage, simulation-based workshop on communicating bad news.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in self-perceived emotions while executing the simulation-based workshop on communication of bad news
Time Frame: Records will be taken after Session 2 (Simulation Day, April 8, 2027) and Session 3 (Debriefing Day, April 15, 2027).

Participants will record their self-perceived emotions (emotional reflections) by writing about their feelings, emotions, and sensations in a logbook.

Records will be taken after Session 2 (Simulation Day, April 8, 2027) and Session 3 (Debriefing Day, April 15, 2027).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Director: Matteo Martinato, PhD, University of Padova

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2027

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

August 1, 2027

Study Registration Dates

First Submitted

December 16, 2025

First Submitted That Met QC Criteria

January 5, 2026

First Posted (Actual)

January 14, 2026

Study Record Updates

Last Update Posted (Actual)

October 6, 2026

Last Update Submitted That Met QC Criteria

October 1, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • AEI-Sim-2025-01

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.